Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
Keine aktuellen Veranstaltungen.
Vergangene Veranstaltungen (max. 10)
-
WiSe 2021
-
SoSe 2021
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Antibiotic resistance of urinary pathogens after kidney transplantation : A 10-year single-center survey in GermanyIn: Infection - A Journal of Infectious Disease, Jg. 53, 2025, Nr. 5, S. 1755 – 1768DOI (Open Access)
-
Iptacopan Reduces Proteinuria and Stabilizes Kidney Function in C3 GlomerulopathyIn: Kidney International Reports, Jg. 10, 2025, Nr. 2, S. 432 – 446DOI (Open Access)
-
Early CYP3A5 Genotype-Based Adjustment of Tacrolimus Dosage Reduces Risk of De Novo Donor-Specific HLA Antibodies and Rejection among CYP3A5-Expressing Renal Transplant PatientsIn: Diagnostics, Jg. 14, 2024, Nr. 19, 2202DOI (Open Access)
-
Hepatitis-C-Therapie vor und nach Nierentransplantation: Was ist heute möglich?In: Die Nephrologie, Jg. 19, 2024, Nr. 2, S. 87 – 94
-
Risk Stratification Before Living Donor Kidney Transplantation in Patients With Preformed Donor-specific Antibodies by Different Crossmatch MethodsIn: Transplantation Direct, Jg. 10, 2024, Nr. 9, e1680DOI (Open Access)
-
Urinary Biomarkers for Cell Cycle Arrest TIMP-2 and IGFBP7 for Prediction of Graft Function Recovery after Kidney TransplantationIn: International Journal of Molecular Sciences (IJMS), Jg. 25, 2024, Nr. 8, 4169DOI (Open Access)
-
Efficacy and Safety of Iptacopan in Patients With C3 GlomerulopathyIn: Kidney International Reports, Jg. 8, 2023, Nr. 12, S. 2754 – 2764DOI (Open Access)
-
Expression of Interferon Regulatory Factor 8 (IRF8) and Its Association with Infections in Dialysis PatientsIn: Cells, Jg. 12, 2023, Nr. 14, 1892DOI, Online Volltext (Open Access)
-
The Tacrolimus Concentration/Dose Ratio Does Not Predict Early Complications After Kidney TransplantationIn: Transplant International, Jg. 36, 2023, 11027DOI (Open Access)
-
Worse cardiovascular and renal outcome in male SLE patientsIn: Scientific Reports, Jg. 13, 2023, Nr. 1, 18628DOI (Open Access)
-
CC Genotype of GNAS c.393C>T (rs7121) Polymorphism Has a Protective Effect against Development of BK Viremia and BKV-Associated Nephropathy after Renal TransplantIn: Pathogens, Jg. 11, 2022, Nr. 10, 1138DOI (Open Access)
-
Cumulative mean fluorescent intensities of HLA specific antibodies predict antibody mediated rejections after kidney transplantationIn: HLA: Immune Response Genetics (Human Leukocyte Antigens), Jg. 100, 2022, Nr. 6, S. 553 – 562DOI (Open Access)
-
Development Of De Novo Donor-Specific HLA Antibodies and ABMR in Renal Transplant Patients Depends on CYP3A5 GenotypeIn: Transplantation, Jg. 106, 2022, Nr. 5, S. 1031 – 1042DOI (Open Access)
-
Differential Treatment Effects for Renal Transplant Recipients With DSA-Positive or DSA-Negative Antibody-Mediated RejectionIn: Frontiers in Medicine, Jg. 9, 2022, 816555DOI, Online Volltext (Open Access)
-
GNB3 c.825C>T (rs5443) Polymorphism and Risk of Acute Cardiovascular Events after Renal Allograft TransplantIn: International Journal of Molecular Sciences (IJMS), Jg. 23, 2022, Nr. 17, 9783DOI, Online Volltext (Open Access)
-
Influence of Immunosuppressive Regimen on Diffusivity and Oxygenation of Kidney Transplants : Analysis of Functional MRI Data from the Randomized ZEUS TrialIn: Journal of Clinical Medicine (JCM), Jg. 11, 2022, Nr. 12, 3284DOI (Open Access)
-
Kidney Transplantation After Rescue Allocation - the Eurotransplant Experience : A Retrospective Multicenter Outcome AnalysisIn: Transplantation, Jg. 106, 2022, Nr. 6, S. 1215 – 1226DOI, Online Volltext (Open Access)
-
Noninvasive Diagnosis of Acute Rejection in Renal Transplant Patients Using Mass Spectrometric Analysis of Urine Samples : A Multicenter Diagnostic Phase III TrialIn: Transplantation Direct, Jg. 8, 2022, Nr. 5, e1316DOI (Open Access)
-
Autoimmune glomerulonephritis in a multiple sclerosis patient after cladribine treatmentIn: Multiple Sclerosis Journal, Jg. 27, 2021, Nr. 12, S. 1960 – 1964DOI (Open Access)
-
Characterization of follicular T helper cells and donor-specific T helper cells in renal transplant patients with de novo donor-specific HLA-antibodiesIn: Clinical Immunology, Jg. 226, 2021, S. 108698
-
Comparison of Humoral and Cellular CMV Immunity in Patients Awaiting Kidney TransplantationIn: Diagnostics, Jg. 11, 2021, Nr. 9, 1688DOI, Online Volltext (Open Access)
-
Einsatz von Clazakizumab bei der späten humoralen AbstoßungIn: Der Nephrologe, Jg. 16, 2021, Nr. 5, S. 303 – 304
-
Establishment of an elispot assay to detect cellular immunity against s. Pneumoniae in vaccinated kidney transplant recipientsIn: Vaccines, Jg. 9, 2021, Nr. 12, 1438DOI (Open Access)
-
Impaired humoral response in renal transplant recipients to sars-cov-2 vaccination with bnt162b2 (Pfizer-biontech)In: Viruses, Jg. 13, 2021, Nr. 5, 756DOI, Online Volltext (Open Access)
-
Norovirus Infections in Kidney Transplant RecipientsIn: Transplantation, Jg. 105, 2021, Nr. 12, S. 2655 – 2660
-
Low efficacy of vaccination against serogroup B meningococci in patients with atypical hemolytic uremic syndromeIn: Bioscience Reports, Jg. 40, 2020, Nr. 3, S. BSR20200177DOI, Online Volltext (Open Access)
-
Evidence-based practice : Guidance for using everolimus in combination with low-exposure calcineurin inhibitors as initial immunosuppression in kidney transplant patientsIn: Transplantation Reviews, Jg. 33, 2019, Nr. 4, S. 191 – 199DOI (Open Access)
-
Preformed Donor-Specific HLA Antibodies in Living and Deceased Donor Transplantation : A Multicenter StudyIn: Clinical Journal of the American Society of Nephrology, Jg. 14, 2019, Nr. 7, S. 1056 – 1066
-
Prevalence of active hepatitis E virus infection and efficacy of ribavirin treatment in renal allograft recipientsIn: Transplant Infectious Disease, Jg. 21, 2019, Nr. 3, e13088
-
Randomized, open-label, comparative phase IV study on the bioavailability of Ciclosporin Pro (Teva) versus Sandimmun® Optoral (Novartis) under fasting versus fed conditions in patients with stable renal transplantsIn: BMC Nephrology, Jg. 20, 2019, Nr. 1, 167DOI, Online Volltext (Open Access)
-
Sex-Specific Differences in HLA Antibodies after Pneumococcal Vaccination in Kidney Transplant RecipientsIn: Vaccines, Jg. 7, 2019, Nr. 3, S. 84DOI, Online Volltext (Open Access)
-
Successful early sofosbuvir-based antiviral treatment after transplantation of kidneys from HCV-viremic donors into HCV-negative recipientsIn: Transplant Infectious Disease, Jg. 21, 2019, Nr. 5, S. e13146DOI (Open Access)
-
Susceptibility of BAFF-var allele carriers to severe SLE with occurrence of lupus nephritisIn: BMC Nephrology, Jg. 20, 2019, 430DOI, Online Volltext (Open Access)
-
Treatment With Grazoprevir/Elbasvir for Renal Transplant Recipients With Chronic Hepatitis C Virus Infection and Impaired Allograft Function.In: Transplantation Direct, Jg. 5, 2019, Nr. 1, S. e419DOI, Online Volltext (Open Access)
-
Verwendung HBV- oder HCV-infizierter Spenderorgane bei der Leber- und NierentransplantationIn: Der Gastroenterologe, Jg. 14, 2019, Nr. 4, S. 260 – 268
-
Author Correction : Glomerulocapillary miRNA response to HLA-class I antibody in vitro and in vivoIn: Scientific Reports, Jg. 8, 2018, Nr. 1, S. 6003DOI (Open Access)
-
Effect of ABO incompatibility on T-cell flow cytometry cross-match results prior to living donor kidney transplantationIn: Cytometry Part B: Clinical Cytometry, Jg. 94, 2018, Nr. 4, S. 623 – 630DOI, Online Volltext (Open Access)
-
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus : an analysis from the randomized ZEUS studyIn: BMC Nephrology, Jg. 19, 2018, Nr. 1, S. 154DOI (Open Access)
-
Immune complexes containing serum B-cell activating factor and immunoglobulin G correlate with disease activity in systemic lupus erythematosusIn: Nephrology Dialysis Transplantation (NDT), Jg. 33, 2018, Nr. 1, S. 54 – 64DOI (Open Access)
-
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy : An analysis of two randomized, multicenter trialsIn: BMC Nephrology, Jg. 19, 2018, Nr. 1, S. 237DOI (Open Access)
-
Pretransplant serum BAFF levels are associated with pretransplant HLA immunization and renal allograft survivalIn: Transplant Immunology, Jg. 47, 2018, S. 10 – 17
-
Serum calcification propensity is independently associated with disease activity in systemic lupus erythematosusIn: PLoS ONE, Jg. 13, 2018, Nr. 1, S. e0188695DOI (Open Access)
-
Successful Treatment of Chronic Hepatitis C Virus Infection with Sofosbuvir and Ledipasvir in Renal Transplant Recipients (vol 101, pg 980, 2017)In: Transplantation, Jg. 102, 2018, Nr. 10, S. E458 – E458
-
Wartelistenmanagement vor NierentransplantationIn: Der Nephrologe, Jg. 13, 2018, Nr. 3, S. 146 – 153
-
Accidental Transmission of Hepatitis C (HCV) Virus from an Organ Donor to Five Transplant Recipients : Early Treatment with Direct Acting Antivirals Successfully Prevents HCV-InfectionIn: Transplant International, Jg. 30, 2017, Nr. Suppl. 4 SI, S. 28 Abstract P02
-
Accidental Transmission of Hepatitis C (HCV) Virus from an Organ Donor to five Transplant Recipients : Early treatment with direct acting Antivrials successfully Prevents Chronic HCV InfectionIn: Transplant International, Jg. 30, 2017, Nr. Suppl. 2 SI, S. 37 - 38 Abstract OS092
-
Feasibility of Elabasvir/Grazoprevir for Trearment of Chronic Hepatitis C Virus Infection in Renal Transplant Recipients with Impaired Allograft FunctionIn: Transplant International, Jg. 30, 2017, Nr. Suppl 4 SI, S. 28 Abstract P01
-
Frühe Umstellung von Cyclosporin auf Everolimus nach Lebendnierentransplantation : 5 Jahresdaten der randomisierten ZEUS-StudieIn: Nieren- und Hochdruckkrankheiten, Jg. 46, 2017, Nr. 3, S. 105 – 117
-
Glomerulocapillary Mirna expression Profiles in Three Different Models of Antibody Mediated Rejection (ABMR)In: Transplant International, Jg. 30, 2017, Nr. Suppl. 2 SI, S. 245 Abstract BOS276
-
Glomerulocapillary miRNA response to HLA-class i antibody in vitro and in vivoIn: Scientific Reports, Jg. 7, 2017, Nr. 1, S. 14554DOI (Open Access)
-
Kidney Transplant Survival in Patients with preformed Donor-Specific HLA Antibodies in Solid-Phase AssaysIn: Transplant International, Jg. 30, 2017, Nr. Suppl. 4 SI, S. 12 - 13 Abstract V085
-
Pretransplant serum Baff Levels are Associated with Pretransplant HLA - Immunization and renal Allograft SurvivalIn: Transplant International, Jg. 30, 2017, Nr. Suppl. 2, S. 101
-
Randomised, open-label, comparative phase IV study on the bioavailability of ciclosporin pro (Teva) versus sandimmun (R) optoral (NOVARTIS) in patients with stable renal transplantsIn: Transplant International, Jg. 30, 2017, Nr. Suppl. 4, S. 33 – 33
-
Renal transplant Patients with DE NOVO Donor-Specific HLA-Antibodies Harbour an increased Fraction of Allospecific T-CELLS and Follicular T-HELPER-CELLSIn: Transplant International, Jg. 30, 2017, Nr. Suppl. 2 SI, S. 17 - 18 Abstract OS027
-
Renal transplant patients with donor-specific antibodies harbour an increased fraction of allospecific T-Cells and follicular T-Helper-CellsIn: HLA: Immune Response Genetics (Human Leukocyte Antigens), Jg. 89, 2017, Nr. 6, S. 348 – 349
-
Rescue allocation and recipient oriented extended allocation in kidney transplantation—influence of the EUROTRANSPLANT allocation system on recipient selection and graft survival for initially nonaccepted organsIn: Transplant International, Jg. 30, 2017, Nr. 12, S. 1226 – 1233
-
Successful treatment of chronic hepatitis C virus infection with sofosbuvir and ledipasvir in renal transplant recipientsIn: Transplantation, Jg. 101, 2017, Nr. 5, S. 980 – 986
-
Transplanting HCV-infected kidneys into uninfected recipientsIn: The New England Journal of Medicine, Jg. 377, 2017, Nr. 11, S. 1103 – 1104DOI, Online Volltext (Open Access)
-
Unacceptable human leucocyte antigens for organ offers in the era of organ shortage : Influence on waiting time before kidney transplantationIn: Nephrology Dialysis Transplantation (NDT), Jg. 32, 2017, Nr. 5, S. 880 – 889
-
Abo incompability has an impact on t-cell flow cytometry crossmatch resultsIn: HLA: Immune Response Genetics (Human Leukocyte Antigens), Jg. 87, 2016, Nr. 4, S. 237
-
Calcification Propensity and Survival among Renal Transplant RecipientsIn: Journal of the American Society of Nephrology (JASN), Jg. 27, 2016, Nr. 1, S. 239 – 248DOI (Open Access)
-
Early conversion from cyclosporine to everolimus following living-donor kidney transplantation : outcomes at 5 years posttransplant in the randomized ZEUS trialIn: Clinical Nephrology, Jg. 85, 2016, Nr. 4, S. 215 – 225
-
Folliculart-Helper-Cells are expanded in renal transplant patients with donor specificantbodiesIn: Nephrology Dialysis Transplantation (NDT), Jg. 31, 2016, Nr. Suppl. 1, S. 308
-
Immune complexes containing serum b-cell activating factor and immunoglobulin G correlate with disease activity in systemic lupus erythematosusIn: Clinical and Experimental Rheumatology, Jg. 34, 2016, Nr. 4 Suppl. 99, S. 29
-
Renal Blood Oxygenation Level-dependent Imaging in Longitudinal Follow-up of Donated and Remaining KidneysIn: Radiology, Jg. 279, 2016, Nr. 3, S. 795 – 804
-
What Do BOLD MR Imaging Changes in Donors' Remaining Kidneys Tell Us? : ResponseIn: Radiology, Jg. 281, 2016, Nr. 2, S. 653 – 655DOI, Online Volltext (Open Access)
-
Five-Year Outcomes in Kidney Transplant Patients Converted From Cyclosporine to Everolimus : The Randomized ZEUS StudyIn: American Journal of Transplantation, Jg. 15, 2015, Nr. 1, S. 119 – 128
-
Serum calcification propensity is associated with renal resistance index and mortality after renal transplantationIn: Nephrology Dialysis Transplantation (NDT), Jg. 30, 2015, Nr. Suppl. 3, S. iii372
-
The Reuse of Immunoadsorption Columns in ABO-Incompatible Kidney Transplantation Is Efficient : The Swiss ExperienceIn: Transplantation, Jg. 99, 2015, Nr. 5, S. 1030 – 1035
-
Efficacy and safety of conversion from cyclosporine to everolimus in living-donor kidney transplant recipients : an analysis from the ZEUS studyIn: Transplant International, Jg. 27, 2014, Nr. 11, S. 1192 – 1204
-
Living renal allograft transplantation : diffusion-weighted MR imaging in longitudinal follow-up of the donated and the remaining kidneyIn: Radiology, Jg. 270, 2014, Nr. 3, S. 800 – 808
-
Post Hoc Analysis of ZEUS and HERAKLES, Two Prospective, Open-Label, Multicenter, Randomized Trials : Onset and Progression of Diabetes in Kidney Transplant Recipients On Cyclosporine Standard or Converted to CNI-Free or CNI-Low Everolimus RegimenIn: Transplantation, Jg. 98, 2014, Nr. Suppl. 1, S. 145 – 146
-
Post Hoc Subgroup Analysis of ZEUS : Outcome On Renal Function, Efficacy and Safety in Living-Donor Kidney Transplant Recipients After Conversion From a Calcineurin Inhibitor to an Everolimus Based RegimenIn: American Journal of Transplantation, Jg. 14, 2014, Nr. Suppl. 3, S. 613
-
Post Hoc Subgroup Analysis of ZEUS : Outcome On Renal Function, Efficacy and Safety in Living-Donor Kidney Transplant Recipients After Conversion From a Calcineurin Inhibitor to an Everolimus Based RegimenIn: Transplantation, Jg. 98, 2014, Nr. Suppl. 1, S. 613
-
Pretransplant DSA But Not Complement Fixing HLA Antibodies Are Associated with Increased Risk for Antibody Mediated Rejection in Kidney TransplantationIn: American Journal of Transplantation, Jg. 14, 2014, Nr. Suppl. 3, S. 679
-
Pretransplant DSA But Not Complement Fixing HLA Antibodies Are Associated with Increased Risk for Antibody Mediated Rejection in Kidney TransplantationIn: Transplantation, Jg. 98, 2014, Nr. Suppl. 1, S. 679
-
Reference values and factors associated with renal resistive index in a family-based population studyIn: Hypertension, Jg. 63, 2014, Nr. 1, S. 136 – 142
-
The Swiss Systemic lupus erythematosus Cohort Study (SSCS) : cross-sectional analysis of clinical characteristics and treatments across different medical disciplines in SwitzerlandIn: Swiss Medical Weekly, Jg. 144, 2014, w13990DOI (Open Access)
-
5 Years Follow-Up on renal Function - Zeus Trial : Improved Renal Function of an Everolimus/Enteric-Coated Mycophenolate Sodium regimen after Calcineurin Inhibitor Withdrawal in De Novo Renal Transplant PatientsIn: Transplant International, Jg. 26, 2013, Nr. Suppl. 1, S. 21 Abstract SI V76
-
5-Year Follow-up on the Zeus KTX Trial : Everolimus Conversion after CNI WithdrawalIn: Transplant International, Jg. 26, 2013, Nr. Suppl. 2, S. 81 Abstract BO142
-
A Post HOC Analysis of 2 Prospective, open-label, multicenter, randomized trials : Onset and Progression of Diabetes in Kidney Transplant Patients Receiving Everolimus or Cyclosporine. Results from Zeus and HeraklesIn: Transplant International, Jg. 26, 2013, Nr. Suppl. 1, S. 21 Abstract V78
-
Arterial Stiffness Depends on Serum Ionized Calcium Levels During Dialysis With Regional Citrate AnticoagulationIn: Artificial Organs, Jg. 37, 2013, Nr. 5, S. 467 – 474
-
Circulating Angiopoetin-2 Levels are Correlated with Renal Resistance Index and Predict Mortality in Kidney Allograft RecipientsIn: Transplant International, Jg. 26, 2013, Nr. Suppl. 2, S. 153 Abstract BO287
-
Diffusion-Weighted magnetic resonance imaging befor and after Donor Nephrectomy : Longitudinal Follow-up reveals functional Changes of the remaining kidney in DonorsIn: Transplant International, Jg. 26, 2013, Nr. Suppl. 1, S. 9 Abstract V26
-
Heritability, determinants and reference values of renal length : A family-based population studyIn: European Radiology, Jg. 23, 2013, Nr. 10, S. 2899 – 2905DOI, Online Volltext (Open Access)
-
Improved Renal Function of an Everolimus/Enteric-Coated Mycophenolate Sodium Regimen after Calcineurin Inhibitor Withdrawal in De Novo Renal Transplant Patients : 5 Years Follow-Up of the ZEUS TrialIn: American Journal of Transplantation, Jg. 13, 2013, Nr. Suppl. 5, S. 35 - 36 Abstract 18
-
Medication adherence assessment : High accuracy of the new ingestible sensor system in kidney transplantsIn: Transplantation, Jg. 96, 2013, Nr. 3, S. 245 – 250
-
Improved Renal Function of an Everolimus/Enteric-Coated Mycophenolate Sodium Regimen after Calcineurin Inhibitor Withdrawal in De Novo Renal Transplant Patients : 4 Years Follow-Up of the ZEUS TrialIn: American Journal of Transplantation, Jg. 12, 2012, Nr. Suppl. 3, S. 298
-
Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants : An open-label, randomised, controlled trialIn: Lancet, Jg. 377, 2011, Nr. 9768, S. 837 – 847
-
Improved Renal Function of an Everolimus/Enteric-Coated Mycophenolate Sodium Regimen after Calcineurin Inhibitor Withdrawal in De Novo Renal Transplant Patients : 3 Years Follow-Up of the ZEUS TrialIn: American Journal of Transplantation, Jg. 11, 2011, Nr. Suppl. 2, S. 66
-
New Onset Diabetes after Transplantation and mTOR Inhibitors : Results of the ZEUS TrialIn: American Journal of Transplantation, Jg. 11, 2011, Nr. Suppl. 2, S. 412 – 413
-
Conversion to an everolimus/enteric-coated mycophenolate sodium regimen after calcineurin inhibitor withdrawal in de novo renal transplant patients improves renal function : 2 years follow-up oft he zeus trial
19th Annual Congress of the German Transplantation Society, Hamburg, Germany, 7‐9 October 2010,In: Transplant International, Jg. 23 Suppl., 2010, S. 0172 -
Post Hoc Subground analysisi freom ZEUS : Outcome on renl Function, efficacy and safety ub Living-Donor kidney TRANSPLANT RECIPIENTS AFTER CONVERSION FROM A CALCINEURIN INHIBITOR TO AN EVEROLIMUS BASED REGIMENIn: Transpl Int / 22nd Annual Meeting of the German Transplantation Society. Frankfurt am Main, Germany. October 24-26, 2013, Jg. 26, 2013, Nr. Suppl.1, S. 8 Abstract V22
-
Update NierentransplantationIn: Die Nephrologie. Berlin: Springer Science, Jg. 19, 2024, Nr. 2, S. 67 – 68DOI (Open Access)
-
Enhanced cellular cmv immunity in immunosuppressed patients awaiting kidney transplantationIn: HLA: Immune Response Genetics (Human Leukocyte Antigens). Hoboken: Wiley-Blackwell - STM, Jg. 98, 2021, Nr. Suppl. 1, e00690-21
-
Development of de Novo Anti-HLA-DSA in renaö transplant patients depends on CYP3A5 genotypeIn: Transplant International. Lausanne: Frontiers Media, Jg. 33, 2020, Nr. S2, Special Issue: Abstracts of the 29th Annual Meeting of the German Transplantation Society, Cologne, Germany, 15–17 October 2020, S. 10 – 11DOI (Open Access)
-
Influence of immunosuppressive regimen on oxygenation and diffusivity of kidney transplants - analysis of functional MRI date from the randomized Zeus StudyIn: Nephrology Dialysis Transplantation (NDT). Oxford: Oxford University Press (OUP), Jg. 35, 2020, Nr. Supplement_3, S. 2098DOI (Open Access)
-
Update to the long-term safety and efficacy of iptacopan in C3G : 33-month extension study data from patients enrolled in a phase 2 study
61st ERA Congress, 23-26 May 2024, Stockholm,In: Nephrology Dialysis Transplantation (NDT). Oxford: Oxford University Press (OUP), Jg. 39, 2020, Nr. Supplement_1: 61st ERA Congress, 23-26 May 2024: Congress Abstracts, S. I254 – I254DOI (Open Access) -
Efficacy of Ribavirin Treatment for Active Hepatitis E Infection in Renal Allograft Recipients
27th Annual Meeting of the German Transplantation Society, Berlin, Germany, 7–10 November 2018,In: Transplant International. Lausanne: Frontiers Media, Jg. 31, 2018, Nr. S5, S. 30DOI (Open Access) -
Kidney Transplant Survival in Patients with Preformed Donor‐Specific HLA Antibodies (DSA) in Solid‐Phase Assays : Results of a Multicenter Study from 18 German Transplant Centers
27th Annual Meeting of the German Transplantation Society, Berlin, Germany, 7–10 November 2018,In: Transplant International. Lausanne: Frontiers Media, Jg. 31, 2018, Nr. S5, S. 15 – 16DOI (Open Access) -
Successful early treatment of HCV viremia after transplantation of HCV positive renal allografts into HCV negative recipients
27th Annual Meeting of the German Transplantation Society, Berlin, Germany, 7–10 November 2018,In: Transplant International. Lausanne: Frontiers Media, Jg. 31, 2018, Nr. Suppl. 5, S. 11 -
Treatment with Grazoprevir/Elbasvir for renal transplant recipients with chronic Hepatitis C Virus Infection and impaired allograft functionIn: Nephrology Dialysis Transplantation (NDT). Oxford: Oxford University Press (OUP), Jg. 33, 2018, Nr. Suppl_1, S. i602 – i603DOI (Open Access)
-
Increased expression of the coinhibitors PD-1 and BTLA on CMV-specific T-Cells is associated with symptomatic CMV infection in renal transplant patientsIn: Transplant International. Lausanne: Frontiers Media, Jg. 30, 2017, Nr. Suppl. 4 SI, S. 21 Abstract PV20
-
Abo blood group incompatibility has an impact on t-cell flow cytometry crossmatch resultsIn: Transplant International. Lausanne: Frontiers Media, Jg. 29, 2016, Nr. Suppl. 3, Special Issue: Abstracts of the 25th Annual Meeting of the German Transplantation Society, Essen, Germany, 5–8 October 2016, S. 25
-
Increased pretransplant serum baff levels are associated with reduced renal allograft survivalIn: Transplant International. Lausanne: Frontiers Media, Jg. 29, 2016, Nr. Suppl. 3, Special Issue: Abstracts of the 25th Annual Meeting of the German Transplantation Society, Essen, Germany, 5–8 October 2016, S. 26
-
Influence of preformed donorspecific HLA-antibodies on kidney transplantation - first results of a multicenter retrospective studyIn: Transplant International. Lausanne: Frontiers Media, Jg. 29, 2016, Nr. Suppl. 3, S. 24
-
Renal transplant patients with donor specific antibodies harbour an increased fraction of allospecific T-Cells and follicular T-Helper-CellsIn: Transplant International. Lausanne: Frontiers Media, Jg. 29, 2016, Nr. Suppl. 3, Special Issue: Abstracts of the 25th Annual Meeting of the German Transplantation Society, Essen, Germany, 5–8 October 2016, S. 16 V091
-
Successful therapy of chronic hepatitis C virus infectionwith sofosbuvir and ledipasvir in renal transplant recipientsIn: Transplant International. Lausanne: Frontiers Media, Jg. 29, 2016, Nr. Suppl. 3, S. 20 – 21
-
Despite intensified immunosuppression flow cytometry crossmatch results are predictive of antibody-mediated rejection
24th Annual Meeting of the German Transplantation Society, 22–24 October 2015, Dresden, Germany,In: Transplant International. Lausanne: Frontiers Media, Jg. 28, 2015, Nr. S2, S. 44 -
Explorative Analysis of ZEUS After 5 Years : Histological Assessment from Biopsy AnalysesIn: American Journal of Transplantation. Amsterdam: Elsevier, Jg. 15, 2015, Nr. Suppl. 3
-
Explorative analysis of ZEUS after 5 years : Histological assessment from biopsy anaysesIn: Transplant International. Lausanne: Frontiers Media, Jg. 28, 2015, Nr. S4, S. 83
-
Explorative post hoc analysis of zeus after 5 years : histological assessments from biopsies
24th Annual Meeting of the German Transplantation Society, 22–24 October 2015, Dresden, Germany,In: Transplant International. Lausanne: Frontiers Media, Jg. 28, 2015, Nr. S2, S. 23 -
Follicular T-Helper Cells are expanded in renal transplant petients with donor specific antibodies
24th Annual Meeting of the German Transplantation Society, 22–24 October 2015, Dresden, Germany,In: Transplant International. Lausanne: Frontiers Media, Jg. 28, 2015, Nr. S2, S. 29 -
Inappropiate high endogenous serum cortisol concentrations in patients with ESRD before and after kidney transplantation
52nd ERA-EDTA Congress, May 28th-31st, 2015, London, UK,In: Nephrology Dialysis Transplantation (NDT). Oxford: Oxford University Press (OUP), Jg. 30, 2015, Nr. Suppl. 3, S. iii370 -
Post hoc subgroup analysis of ZEUS : outcome on renal function, effiacy and safety in living-donor kidney transplant recipients after conversion from a calcineurin inhibitor to an everolimus based regimen : 5 year follow-up data
24th Annual Meeting of the German Transplantation Society, 22–24 October 2015, Dresden, Germany,In: Transplant International. Lausanne: Frontiers Media, Jg. 28, 2015, Nr. S2, S. 58 -
Acoustic radiation force impulse imaging (ARFI) as a tool to quantify tissue elasticity in renal allograft rejection
23rd Annual Meeting of the German Transplantation Society, Mannheim, Germany, 16–18 October 2014,In: Transplant International. Lausanne: Frontiers Media, Jg. 27, 2014, Nr. Suppl. 3, S. 28 – 29 -
Outcome on renal function, efficacy and safety in living-donor kidney transplant recipients after conversion from a calcineurin inhibitor ton everolimus based regimen : a post hoc subgroup analysis of ZEUS
23rd Annual Meeting of the German Transplantation Society, Mannheim, Germany, 16–18 October 2014,In: Transplant International. Lausanne: Frontiers Media, Jg. 27, 2014, Nr. Suppl. 3, S. 24 -
Post Hoc Analysis of ZEUS and HERAKLES, Two Prospective, Open-Label, Multicenter, Randomized Trials : Onset and Progression of Diabetes in Kidney Transplant Recipients On Cyclosporine Standard or Converted to CNI-Free or CNI-Low Everolimus Regimen
World Transplant Congress, 26 – 31 Jul, 2014, San Francisco, USA,In: American Journal of Transplantation. Amsterdam: Elsevier, Jg. 14, 2014, Nr. Suppl.3, S. 145 – 146 -
Post hoc analysis of ZEUS and HERAKLES, two prospective, open-label, multicenter, randomized trials : onset and progression of diabetes in kidney transplant recipients on cyclosporine standard or converted to CNI-free or CNI-low everolimus regimen
23rd Annual Meeting of the German Transplantation Society, Mannheim, Germany, 16–18 October 2014,In: Transplant International. Lausanne: Frontiers Media, Jg. 27, 2014, Nr. Suppl. 3, S. 50 -
Pretransplant DSA but not complement fixing HLA antibodies are associated with increased risk for antibody mediated rejection in kidney transplantation
23rd Annual Meeting of the German Transplantation Society, Mannheim, Germany, 16–18 October 2014,In: Transplant International. Lausanne: Frontiers Media, Jg. 27, 2014, Nr. Suppl. 3, S. 3 -
Pretransplant dsa but not complement fixing HLA antibodies are associated with increaesed risk for antibody mediated rejection in kidney transplantation
28th EFI European Immunogenetics and Histocompatibility Conference Stockholm, Sweden, June 25th–28th, 2014,In: Tissue Antigens. Oxford: Wiley-Blackwell, Jg. 84, 2014, Nr. 1, S. 67 – 68 -
Serum calcification propensity predicts mortality after aenal transplantation
23rd Annual Meeting of the German Transplantation Society, Mannheim, Germany, 16–18 October 2014,In: Transplant International. Lausanne: Frontiers Media, Jg. 27, 2014, Nr. Suppl. 3, S. 38 -
Improved Renal Function of an Everolimus/Enteric-Coated Mycophenolate Sodium Regimen after Calcineurin Inhibitor Withdrawal in De Novo Renal Transplant Patients : 2 Years Follow-Up of the ZEUS TrialIn: American Journal of Transplantation. Amsterdam: Elsevier, Jg. 10, 2010, Nr. Suppl. 4, S. 503
-
Differential Effects of CYP3A4*22 and POR*28 on Tacrolimus Metabolism and Alloimmunization after Kidney Tranplantation in Contrast to CYP3A5 GenotypeIn: Transplant International. Lausanne: Frontiers Media, Jg. 34, 2021, Nr. S2, S. 33DOI (Open Access)